scholarly journals Docetaxel‐based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration‐resistant prostate cancer: Long‐term outcomes

2019 ◽  
Vol 26 (8) ◽  
pp. 797-803 ◽  
Author(s):  
Nobumichi Tanaka ◽  
Kazuo Nishimura ◽  
Eijiro Okajima ◽  
Kenji Ina ◽  
Osamu Ogawa ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Oral Administration ◽  
Castration Resistant Prostate Cancer ◽  
Long Term Outcomes ◽  
Castration Resistant ◽  
Daily Oral Administration

Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer

2018 ◽  
Vol 23 (4) ◽  
pp. 749-756 ◽  
Author(s):  
Rihito Aizawa ◽  
Kenji Takayama ◽  
Kiyonao Nakamura ◽  
Takahiro Inoue ◽  
Takashi Kobayashi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
External Beam Radiotherapy ◽  
External Beam ◽  
Castration Resistant Prostate Cancer ◽  
Long Term Outcomes ◽  
Castration Resistant

Long-Term Androgen Ablation and Docetaxel Up-Regulate Phosphorylated Akt in Castration Resistant Prostate Cancer

2011 ◽  
Vol 185 (6) ◽  
pp. 2376-2381 ◽  
Author(s):  
Takeo Kosaka ◽  
Akira Miyajima ◽  
Suguru Shirotake ◽  
Eriko Suzuki ◽  
Eiji Kikuchi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Castration Resistant Prostate Cancer ◽  
Androgen Ablation ◽  
Castration Resistant ◽  
Phosphorylated Akt
Sign in / Sign up

Export Citation Format

Share Document